The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort

BACKGROUND: Serum fibroblast growth factor 23 (FGF-23) levels are markedly elevated in haemodialysis patients and have been linked to mortality outcomes. Small studies in health and chronic kidney disease, have demonstrated marked intra- and inter-individual variability in measured FGF-23 levels, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Damasiewicz, Matthew J., Lu, Zhong X., Kerr, Peter G., Polkinghorne, Kevan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236962/
https://www.ncbi.nlm.nih.gov/pubmed/30428848
http://dx.doi.org/10.1186/s12882-018-1127-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236962/
https://www.ncbi.nlm.nih.gov/pubmed/30428848
http://dx.doi.org/10.1186/s12882-018-1127-7

Ejemplares similares